Cohance Lifesciences Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	543064	NSE Symbol:	COHANCE	P/E :	149.63
ISIN Demat:	INE03QK01018	Div & Yield %:	0	EPS :	7.1
Book Value:	60.86	Market Cap (Rs. Cr.):	40,643.93	Face Value :	1

Suven Pharmaceuticals receives credit ratings from CRISIL

(28 Feb 2025)

Suven Pharmaceuticals announced that CRISIL has assigned/ reaffirmed the following ratings to the Bank facilities of the Company as under:

Long Term Rating - CRISIL A+/Watch Positive (Continues on 'Rating Watch with Positive Implications')

Short Term Rating - CRISIL A1+ (Reaffirmed)

Company Snapshot